Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Qapzola is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 21, 2017
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Apaziquone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 30, 2015
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase II/ Phase III
Sponsor : HANDOK
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Apaziquone is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 21, 2011
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase II/ Phase III
Sponsor : HANDOK
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Apaziquone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 10, 2011
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Apaziquone is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 05, 2011
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Allergan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)
Details : Apaziquone is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Urinary Bladder Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 15, 2011
Lead Product(s) : Apaziquone
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
